CASP2 and RIPK1 Domain Containing Adaptor with Death Domain (CRADD) (Internal Region) Peptide

Details for Product No. ABIN1381971
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

 
Protein Name
Synonyms MRT34, RAIDD, cradd, MGC89035, zgc:101717, CRADD, DKFZp468A2219, LOC100226369, raidd, MGC78788
Protein Region
Internal Region
Origin
Human
(3)
Application
Blocking Peptide (BP)
Pubmed 3 references available
Catalog no. ABIN1381971
Quantity 0.05 mg
Price
77.00 $   Plus shipping costs $45.00
Shipping to United States (Change)
Availability Will be delivered in 2 to 3 Business Days

Order hotline:

  • +1 404 474 4654
  • +1 888 205 9894 (TF)
Characteristics 19 amino acids near the center of human RAIDD.
Human
Alternative Name RAIDD
Research Area Cancer, Apoptosis/Necrosis
Application Notes RAIDD peptide is used for blocking the activity of RAIDD.
Restrictions For Research Use only
Format Liquid
Concentration 200 µg/mL
Buffer PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
Preservative Sodium azide
Storage -20 °C
Expiry Date 12 months
Background publications Choe, Farzan, Sun et al.: "The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates." in: Cell, Vol. 85, Issue 7, pp. 1135-48, 1996 (PubMed).

Duan, Dixit: "RAIDD is a new 'death' adaptor molecule." in: Nature, Vol. 385, Issue 6611, pp. 86-9, 1997 (PubMed).

He, Chen, Farzan et al.: "CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia." in: Nature, Vol. 385, Issue 6617, pp. 645-9, 1997 (PubMed).

Reactivities (3)
back to top